Gene Biotherapeutics Inc (CRXM) - Financial and Strategic SWOT Analysis Review

Gene Biotherapeutics Inc (CRXM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Gene Biotherapeutics Inc (Gene Biotherapeutics), formerly known as Taxus Cardium Pharmaceuticals Group Inc, is a development stage company with focus on regenerative medicine. It develops manufacturing process and technology platforms for cardiovascular disease, wound healing and tissue engineering based on its core gene therapy. Its product portfolio includes FDA approved Excellagen topical gel, a cellular biological skin substitute used for wound care management; and Generx, an interventional cardiology, angiogenic gene therapy product candidate used for the treatment of cardiac microvascular insufficiency. The company also holds non-core interests in the Cell-nique d/b/a Healthy Brands Collective, a health products company, and LifeAgain Insurance Solutions, Inc., an advanced medical data analytics business. It markets its products through third party commercialization partners. Gene Biotherapeutics is headquartered in San Diego, California, the US.

Gene Biotherapeutics Inc Key Recent Developments

Jan 08,2018: Taxus Cardium Announces Name Change To Gene Biotherapeutics

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Gene Biotherapeutics Inc - Key Facts 5
Gene Biotherapeutics Inc - Key Employees 6
Gene Biotherapeutics Inc - Key Employee Biographies 7
Gene Biotherapeutics Inc - Major Products and Services 8
Gene Biotherapeutics Inc - History 9
Gene Biotherapeutics Inc - Company Statement 12
Gene Biotherapeutics Inc - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 Company Analysis 14
Company Overview 14
Gene Biotherapeutics Inc - Business Description 15
Gene Biotherapeutics Inc - Corporate Strategy 16
Gene Biotherapeutics Inc - SWOT Analysis 17
SWOT Analysis - Overview 17
Gene Biotherapeutics Inc - Strengths 17
Gene Biotherapeutics Inc - Weaknesses 18
Gene Biotherapeutics Inc - Opportunities 19
Gene Biotherapeutics Inc - Threats 20
Gene Biotherapeutics Inc - Key Competitors 21
Section 3 Company Financial Ratios 22
Financial Ratios - Capital Market Ratios 22
Financial Ratios - Annual Ratios 23
Performance Chart 25
Financial Performance 25
Financial Ratios - Interim Ratios 26
Financial Ratios - Ratio Charts 27
Section 4 Companys Lifesciences Financial Deals and Alliances 28
Gene Biotherapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 28
Gene Biotherapeutics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 29
Gene Biotherapeutics Inc, Recent Deals Summary 30
Section 5 Companys Recent Developments 31
Jan 08, 2018: Taxus Cardium Announces Name Change To Gene Biotherapeutics 31
Section 6 Appendix 32
Methodology 32
Ratio Definitions 32
About GlobalData 36
Contact Us 36
Disclaimer 36

List Of Tables


Gene Biotherapeutics Inc, Key Facts 5
Gene Biotherapeutics Inc, Key Employees 6
Gene Biotherapeutics Inc, Key Employee Biographies 7
Gene Biotherapeutics Inc, Major Products and Services 8
Gene Biotherapeutics Inc, History 9
Gene Biotherapeutics Inc, Subsidiaries 13
Gene Biotherapeutics Inc, Key Competitors 21
Gene Biotherapeutics Inc, Ratios based on current share price 22
Gene Biotherapeutics Inc, Annual Ratios 23
Gene Biotherapeutics Inc, Annual Ratios (Cont...1) 24
Gene Biotherapeutics Inc, Interim Ratios 26
Gene Biotherapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 28
Gene Biotherapeutics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 29
Gene Biotherapeutics Inc, Recent Deals Summary 30
Currency Codes 32
Capital Market Ratios 32
Equity Ratios 33
Profitability Ratios 33
Cost Ratios 34
Liquidity Ratios 34
Leverage Ratios 35
Efficiency Ratios 35

List Of Figures


Gene Biotherapeutics Inc, Performance Chart (2012 - 2016) 25
Gene Biotherapeutics Inc, Ratio Charts 27
Gene Biotherapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 28
Gene Biotherapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 29

Andhra Pradesh Power Generation Corp Ltd - Strategic SWOT Analysis Review

Andhra Pradesh Power Generation Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed

USD 125 View Report

Electricity Generation Company of Bangladesh Ltd - Strategic SWOT Analysis Review

Electricity Generation Company of Bangladesh Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed

USD 125 View Report

Stealth BioTherapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Stealth BioTherapeutics Inc (Stealth), formerly Stealth Peptides Inc is a clinical stage biopharmaceutical company that develops therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of

USD 250 View Report

Aeglea BioTherapeutics Inc (AGLE) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Aeglea BioTherapeutics Inc (Aeglea BioTherapeutics), formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops and commercializes engineered human enzymes for the treatment of cancer and rare genetic diseases.

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available